Last year, the US Food and Drug Administration approved the first drug specifically marketed for restless leg syndrome, and earlier this year, Mayo Clinic researchers reported that the drug Requip can significantly improve the annoying symptoms and improve sleep for many of the 20 million Americans who have the neurological problem. A similar drug called Mirapex is up for FDA review now.